Interview article with Prof. Abdelmoity, discussing the current treatment landscape for patients with drug-resistant epilepsy (DRE), navigating the unmet needs and integral challenges within patient management, including the need for clearly defined treatment algorithms and utilisation of non-pharmacological treatment modalities, as well as looking to future treatment approaches for patients who are non-responsive to anti-seizure medications (ASM).
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Latest articles
All articles


